To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
| DRAVP ID | Peptide Name | Source | Target Organism | Pubmed ID |
|---|---|---|---|---|
| DRAVPe01981 | Peptide1(ACE2 (21-43)[N13Q,A16V,D18E,L19I,F20Y,Y21W]) | Synthetic construct | SARS-CoV-2 | 34328726 |
| DRAVPe01982 | Peptide2 | Synthetic construct | SARS-CoV-2 | 34328726 |
| DRAVPe01983 | Peptide3 | Synthetic construct | SARS-CoV-2 | 34328726 |
| DRAVPe01984 | Peptide4 | Synthetic construct | SARS-CoV-2 | 34328726 |
| DRAVPe01985 | Peptide5 | Synthetic construct | SARS-CoV-2 | 34328726 |
| DRAVPe01986 | Peptide6 | Synthetic construct | SARS-CoV-2 | 34328726 |
| DRAVPe01987 | None | Synthetic construct | HBV | 12469306 |
| DRAVPe01988 | None | Synthetic construct | HBV | 12469306 |
| DRAVPe01989 | None | Synthetic construct | HBV | 12469306 |
| DRAVPe01990 | HBV S(56-80) | Synthetic construct | HBV | 12469306 |
| DRAVPe01991 | K5-66 | Synthetic construct | HCV | 22965230 |
| DRAVPe01992 | K5-66-A | Synthetic construct | HCV | 22965230 |
| DRAVPe01993 | K6-10 | Synthetic construct | HCV | 22965230 |
| DRAVPe01994 | K6-10-A | Synthetic construct | HCV | 22965230 |
| DRAVPe01995 | CP5-46 | Synthetic construct | HCV | 22965230 |
| DRAVPe01996 | CP5-46-4D5E | Synthetic construct | HCV | 22965230 |
| DRAVPe01997 | CP5-46-A | Synthetic construct | HCV | 22965230 |
| DRAVPe01998 | CP5-46A-4D5E | Synthetic construct | HCV | 22965230 |
| DRAVPe01999 | Ant-CP5-46A-4D5E | Synthetic construct | HCV | 22965230 |
| DRAVPe02000 | peptide 1 | Synthetic construct | DENV | 36739680 |
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.